ResearcherMoffitt Cancer CenterNo recent work listed
Jonathan Strosberg
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 0
- Pancreatic cancer trials
- 6 (principal investigator on 6)
- Pancreatic cancer grants
- 0
- Collaborators
- 1
2006: 1 trial · 2007: 1 trial · 2008: none · 2009: none · 2010: none · 2011: 1 trial · 2012: none · 2013: none · 2014: none · 2015: 1 trial · 2016: none · 2017: 2 trials
Trials 6
- Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors Principal investigator NCT02948946↗
- FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Principal investigator NCT03042780↗
- Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors Principal investigator NCT02575300↗
- Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) Principal investigator NCT01253161↗
- Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Principal investigator NCT00609765↗
- Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization Principal investigator NCT00434109↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.